Trial Details

Trial status:

Closed

Recruitment start date:

05/12/2007

Funder:

Leukaemia Research Fund

Sponsor:

UCL

Chief Investigator:

Andrew McMillan

Recruitment target:

N/A

EudraCT number:

2005-003479-19

Contact details:

CTC.Rcodox@ucl.ac.uk

Note: For enquiries only. DO NOT use for clinical referrals.

R-CODOX-M/IVAC (aka RCM)

R-CODOX-M/IVAC: A Phase II Single Arm Study of the use of CODOX-M/IVAC with Rituximab (R-CODOX-M/IVAC) in the treatment of patients with Diffuse Large B-Cell Lymphoma (DLBCL) or Burkitt’s Lymphoma (BL) of International Prognostic Index (IPI) High or High I

Description

Design:

Treatment:

Key inclusion/exclusion criteria:

Duration of recruitment:

Aim

Contact the trial team

View trial documents

Trial protocols

Trial protocols must not be applied to patients treated outside trials. UCL CTC can only ensure that approved trial investigators are provided with amendments to protocols.

Name	Version	Current vers	Release date	Download
Protocol v8.2	8.2	Current

Trial documents

Name	Type	Version	Current vers	Release date	Download
R-CODOX-M/IVAC Burkitt's lymphoma paper	Other	N/A	Current	12/03/2020
R-CODOX-M/IVAC DLBCL paper	Other	N/A	Current	26/05/2020

Cancer Research UK & UCL Cancer Trials Centre
University College London
90 Tottenham Court Road
London
W1T 4TJ

View map

Email:
ctc.enquiries@ucl.ac.uk
Telephone:
+44 (0)20 7679 9898 (General CTC Enquiries)
Fax:
020 7679 9899

CTC staff

University College London, Gower Street, London, WC1E 6BT +44 (0)20 7679 2000